54:38

Mechanisms of Arrhythmia after Cardiac Stem Cell Therapy

01:01:11

Tetralogy of Fallot

01:01:11

Rheumatic Heart Disease and Cardiovascular Capacity Building in Africa

01:01:03

Cardiovascular Genetics from Diagnosis to Therapy

01:02:23

Methamphetamine-Associated Cardiomyopathy

01:00:21

Towards Individualized Care in Thoracic Aortic Disease

01:03:38

Applications of TranscatheterElectrosurgery

57:34

Ischemic Cardiomyopathy: From Palliation and Treatment to Prevention

59:34

Looking for Some Hot Stuff: FDG-avidity in Genetic Cardiomyopathy

02:51:55

New Horizons: Aortic Stenosis and the Dynamic Landscape of Practice Management

50:39

Artificial Intelligence for Opportunistic Screening of Cardiovascular Disease

58:53

Are Women’s Hearts Different Than Men’s Hearts?

01:04:27

Diuretic resistance: the bane of cardiology and nephrology’s existence

01:08:50

Commercialization within academia: case studies from a career in progress

57:26

Localizing the Lesion: Diagnosis and Management of Cardioembolic Stroke

01:01:43

Improving Quality of Care and Outcomes in Heart Failure

56:06

Using Artificial Intelligence to Predict Shock-Refractory Ventricular Fibrillation

57:15

TAVR: A Translational Science Perspective

01:00:33

Multidisciplinary Approach to Complex Aortic Disease

52:48

Global Differences In Heart Failure Etiology, Treatment, and Outcomes

01:01:02

Coronary Microvascular Disease: X Marks the Spot

55:54

Clinicopathologic Correlation

01:00:17

Artificial Intelligence in Cardiology: where we are and where we are

01:02:31

Advanced Therapies for ACHD Patients

59:19

Clinical Cardioethical Conference: Tales from Two Cities

53:00

Mitral Regurgitation: Evolution of Surgical and Percutaneous Therapies

53:05

Chronic Critical Illness & Post Intensive Care Syndrome: Prevention and Treatment

59:00

The Power of Arteriovenous Gradients

56:28

The Past, Present, & Future of Cardiovascular Care in the Oncology Patient

59:43

Device therapy in heart failure: a new look at cardiac contractility modulation therapy

01:02:41

Temperature drives cardiac function

01:01:18

There Ain't No Such Thing as a Free Lunch Valve Disease, Anticoagulation, and Pregnancy

59:45

Revolutionary Perspectives in Heart Failure: A 45 - Year Journey

01:03:44

Navigating the limitations and challenges of wearable technologies in cardiac arrhythmia care

45:19

Clinicopathologic Conference

54:55

Ambulatory Cardiology Billing: Current and Future Practices

01:00:38

Women & Cardiovascular Disease: Is there Really a Sex Difference?

55:25

Critical appraisal of the rationale for chronic total occlusion percutaneous coronary intervention

47:29

Cardiac Regenerative Therapy–is it viable?

01:03:52

Raising the Bar for Cardiovascular Health: A Review of Resistance Training

01:02:31

Role of Imagenomics in Enhancing Cardiovascular Health Throughout the Lifespan

01:00:44

Beyond Statins: limitations of statin therapy and emerging alternatives

56:51

Targeting Inflammation in Heart Failure and Myocarditis

01:02:44

Cardiomyopathy Genetics: Current & Evolving Applications

01:03:52

Performance evaluation and the myth of the bad apple: Lessons from VA

53:35

Pathology Conference

59:41

Measure what Matters: A concierge approach to accelerating cardiovascular research

01:03:23

Myocardial Recovery: What Have We Learned and Future Directions

40:19

Regulators of Fibroblast Fate & Fibrosis

59:30

Updates on Renal Denervation

58:44

Predicting and Preventing Sudden Cardiac Death in Patients Without Systolic Dysfunction

55:09

Cardiology Grand Rounds Clinicopathological Correlation

01:02:53

Health Inequities in Chronic Kidney Disease in African Americans and Blacks

01:03:03

Palliative Care for the Heart Failure Patient

50:03

Low ejection fraction coronary revascularization: A surgical perspective

55:54

Current and Emerging Approaches to Pulmonary Hypertension

01:01:13

Sarcomere modulation: a new era in management of cardiomyopathies

01:04:08

Lost in translation: what can we learn from studies of determinants of SCA in the general population

50:34

Cardioethics of Heart Procurement after Cardiac Death

58:58

Emerging strategies in the management of ATTR amyloidosis